🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHas anyone dealt with oral semaglutide 50mg (rybelsus hd)?

Has anyone dealt with oral semaglutide 50mg (rybelsus hd)?

Dr.SleepRoch Wed, Apr 16, 2025 at 7:41 AM 33 replies 1,762 viewsPage 1 of 7
This thread is more than 13 months old. Information may be outdated. Consider searching for more recent discussions.
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Apr 16, 2025 at 7:41 AM#1

Read the primary source rather than the write-up and the two do not agree, so here is what is actually in it.

Orforglipron is the more interesting oral story because it is not a peptide at all. Being a small molecule it does not need SNAC, does not need the fasting window, and has oral bioavailability in the tens of percent rather than about one.

Where I think it is weakest: the subgroup findings are the part I trust least — with enough subgroups something is always significant, and these were not all pre-registered.

The bit I cannot resolve on my own is how much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly. Practical detail welcome, however dull — the duller the better.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
14 9sarah_TO, wendy_avl, jason_paloalto and 11 others
Reply Quote Save Share Report
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Apr 16, 2025 at 8:43 AM#2
Dr.SleepRoch said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

Agreeing with Dr.SleepRoch, and the qualification matters more than the agreement. The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to get there because almost none of the tablet is absorbed. The dose numbers are not comparable across routes and quoting them side by side confuses people.

13 8JessicaM_2024, TomFromTexas, mike.trainer_LA and 10 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Apr 16, 2025 at 9:45 AM#3
Dr.SleepRoch said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

12 7BrianDallas92, labquiet_amy, emily_PDX and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Apr 16, 2025 at 10:47 AM#4

Taking the question as asked, rather than the general version of it. Oral semaglutide is absorbed in the stomach with the help of SNAC, which locally raises pH and protects the peptide long enough to cross. That mechanism is fragile: bioavailability is roughly 1% and highly sensitive to gastric contents, so a mouthful of coffee genuinely changes the exposure. This is why the label wants 30 minutes and no more than half a glass of plain water.

11 6Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 8 others
Reply Quote Save Share Report
tane_welly
Member
234
1,123
Sep 2024
Wellington, NZ
Apr 16, 2025 at 4:41 PM#5
Dr.KarenChen said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

All true, with one condition: that curve is for people who reached the dose on schedule. Anyone who slowed the ladder for tolerability is on a different, flatter curve, and comparing yourself with the published mean will make you feel like a non-responder when you are not.

10 5pam_columbus, nick_SD_fit, ben_calgary and 7 others
Reply Quote Save Share Report
1237

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register